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b-Arrestin1 is a multifunctional protein critically
involved in signal transduction. Recently, it is also
identified as a nuclear transcriptional regulator, but
the underlying mechanisms and physiological sig-
nificance remain to be explored. Here, we identi-
fied b-arrestin1 as an evolutionarily conserved pro-
tein essential for zebrafish development. Zebrafish
embryos depleted of b-arrestin1 displayed severe
posterior defects and especially failed to undergo
hematopoiesis. In addition, the expression of cdx4,
a critical regulator of embryonic blood formation,
and its downstream hox genes were downregulated
by depletion of b-arrestin1, while injection of cdx4,
hoxa9a or hoxb4amRNA rescued the hematopoietic
defects. Further mechanistic studies revealed that
b-arrestin1 bound to and sequestered the polycomb
group (PcG) recruiter YY1, and relieved PcG-medi-
ated repression of cdx4-hox pathway, thus regu-
lating hematopoietic lineage specification. Taken
together, this study demonstrated a critical role of
b-arrestin1 during zebrafish primitive hematopoiesis,
as well as an important regulator of PcG proteins and
cdx4-hox pathway.
INTRODUCTION
b-Arrestins, namely b-arrestin1 and b-arrestin2, play funda-
mental roles in G protein-coupled receptor (GRCR) desensitiza-
tion and internalization in an agonist- dependent manner (Lefko-
witz and Whalen, 2004). Besides, these multifunctional adaptor
proteins canmediate the cross-talk between GPCR and a variety
of signaling pathways through assembling multiple protein com-
plexes (e.g., RAF/MEK/ERK1/2) in the cytoplasm (Shenoy and
Lefkowitz, 2005). Our recent study showed that under d- or k-
opioid receptor stimulations, nuclear b-arrestin1 specifically
accumulates at p27 and c-fos promoters through scaffolding
CREB and histone acetyltransferase p300, thus enhancing local
histone H4 acetylation and gene transcription (Kang et al., 2005).A similar mechanism was also observed during T cell activation,
in which nuclear b-arrestin1 increases Bcl-2 expression and
contributes to CD4+ T cell survival (Shi et al., 2007). These obser-
vations demonstrated that nuclear b-arrestin1 plays an impor-
tant role in signal transduction and transcription regulation
(Berghmans et al., 2005), however, the underlying mechanisms
and physiological significance remain to be elucidated (Beaulieu
and Caron, 2005).
Spatial and temporal gene expression is strictly controlled
during vertebrate development (Reik, 2007), but the potential
roles of b-arrestins during this process have long been elusive.
Targeted deletion of either b-arrestin1 or b-arrestin2 in mice
does not affect their viability, however, double knockout of these
two proteins induces perinatal death due to multiple organ fail-
ures (our unpublished data). This implies that b-arrestin1 and
b-arrestin2 may have important but largely redundant functions
during mammalian development. Previously, b-arrestin2 was
shown to be essential for zebrafish embryogenesis (Wilbanks
et al., 2004), while the information of b-arrestin1 is still lacking,
indicating that zebrafish may serve as an ideal model to study
the function of b-arrestin1 in vertebrate development.
Hematopoiesis is a dynamic process involving the interplay
between lineage-specific transcription factors and epigenetic
regulators (Rice et al., 2007). Two waves of hematopoiesis,
namely, primitive and definitive hematopoiesis, occur sequen-
tially in the intermediate cell mass (ICM) and aorta-gonad-meso-
nephros (AGM) region during zebrafish development (Orkin and
Zon, 2008). Previous studies have shown that transcription
factors cdx4 and cdx1a, which belong to the caudal family of
homeobox-containing genes, play critical roles in the specifica-
tion of hematopoietic lineage through direct hox gene regulation.
Zebrafish embryos depleted of cdx4 and/or cdx1a display
severe hematopoietic defects, as well as aberrant expression
of posterior hox genes (Davidson et al., 2003; Davidson and
Zon, 2006). Importantly, injection of hoxa9a or hoxb7a mRNA
partially rescued those hematopoietic defects, thus establishing
the critical role of cdx-hox pathway in primitive hematopoiesis.
Similarly, ectopic expression of Cdx4 and/or HoxB4 in murine
embryonic stem cells promotes in vitro hematopoietic lineage
differentiation, whereas Cdx genes deficiency significantly
compromises this process (Lengerke et al., 2007; Wang et al.,
2008b; Wang et al., 2005). Previously, Wnt signaling and theCell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc. 535
transcription factor Mespa have been implicated in the regula-
tion of cdx4-hox pathway in zebrafish (Hart et al., 2007; Lengerke
et al., 2008), but whether epigenetic mechanisms could be
involved remains unknown. Recently, a histone H3 lysine 27 de-
methylase UTX was discovered and proven to be essential for
the posterior development of zebrafish embryos, probably
through regulating the expression of hox genes (Lan et al.,
2007). This raises the possibility that histone modifications
such as H3 lysine 27 methylation may participate in the regula-
tion of cdx-hox pathway and zebrafish hematopoiesis.
Polycomb group (PcG) proteins are evolutionarily conserved
transcriptional repressors critically involved in the maintenance
of Hox gene expression patterns along the anterior-posterior
axis (Ringrose and Paro, 2004). Two classical polycomb repres-
sive complexes, namely PRC1 and PRC2, repress gene tran-
scription through catalyzing mono-ubiquitination of histone
H2A (ubH2A) and tri-methylation of histone H3 Lysine 27
(H3K27me3) in the promoter region of their target genes.
Recently, a third complex PhoRC, which contains the DNA-
binding protein Pho/YY1, was identified and shown to recruit
PRC1 and/or PRC2 to target DNA sequence (Schuettengruber
et al., 2007). In contrast to Drosophila, where PcG target sites
are constitutively bound throughout development (Negre et al.,
2006), binding of PcG proteins to their target genes appears
more dynamic in vertebrates. In mouse and human embryonic
stem cells, PcG proteins preferentially bind to the promoter
regions of developmental regulators, including many homeodo-
main-containing transcription factors, and repress their expres-
sion through catalyzing the H3K27me3 modification. Once dif-
ferentiated, these target genes are activated, concomitant with
the loss of PcG proteins (Boyer et al., 2006; Lee et al., 2006).
However, the mechanism by which PcG proteins are dynami-
cally regulated is largely unknown. In this study, we found that
b-arrestin1 is critically involved in zebrafish primitive hematopoi-
esis, where b-arrestin1 binds to and sequesters the PcG recruiter
YY1, thus relieving PcG-mediated repression of cdx4-hox
pathway.
RESULTS
Identification of b-Arrestin1 as An Evolutionarily
Conserved Protein in Zebrafish
Previously, zebrafish b-arrestin2 was identified and shown to
modulate the Hedgehog pathway (Wilbanks et al., 2004).
However, whether b-arrestin1 exists in zebrafish is still unknown.
In the present study, we first cloned the full-length zebrafish b-ar-
restin1 using 50 and 30 rapid amplification of cDNA ends (RACE).
Zebrafish b-arrestin1 contains 418 amino acids, which displays
90% (379/418) identities and 96% (404/418) similarities to
human and mouse b-arrestin1 (see Figure S1A and Table S1
available online). As evident from the phylogenetic tree and
genomic structure analysis, zebrafish b-arrestin1 is closely
related to its mammalian homologs (Figures 1A and 1B). Similar
to human b-arrestins, zebrafish b-arrestin1 resides in both the
nucleus and cytoplasm, while b-arrestin2 mainly localizes in
the cytoplasm under steady state (Figures S1B–S1E). Next, we
analyzed the developmental expression of b-arrestin1 using anti-
body staining, quantitative real-time PCR (qPCR) and whole-536 Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc.mount in situ hybridization (WISH) technologies, which showed
that zebrafish b-arrestin1 was expressed both maternally and
zygotically throughout early development, with relative enrich-
ment in the eyes and brain at later stages (Figures 1C and
S1F–S1L).
To elucidate the function of b-arrestin1 during zebrafish devel-
opment, anti-sense morpholino oligonucleotides were designed
to specifically block the translation of b-arrestin1 mRNAs. Mor-
pholino against zebrafish visual-arrestin was used as a negative
control (Wilbanks et al., 2004), and depletion of b-arrestin1 was
confirmed by western blot in embryos injected with 4 ng of
b-arrestin1morpholino (Figure 1D). b-arrestin1morphants devel-
oped normally until 12 hr post fertilization (hpf), showing delayed
elongation of the tail (Figures S2B and S2E). Significant
abnormalities could be observed at 24 hpf, including shortened
body length, moderate necrosis in the anterior region and
ventrally curved tail (Figures 1E and S2H). Importantly, the
developmental defects of b-arrestin1 morphants could be
rescued by coinjection of human b-arrestin1mRNA, further sup-
porting the specificity of the morpholino and functional conser-
vation of this protein (Figures 1E and 1F). Taken together, we
identified b-arrestin1 as an evolutionarily conserved protein in
zebrafish.
Critical Role of b-Arrestin1 in Zebrafish Hematopoiesis
To further explore the role of b-arrestin1 in zebrafish, develop-
mental marker genes were analyzed using WISH. As controls,
embryos depleted of b-arrestin2 were also analyzed (Figures
S2C, S2F and S2I). Consistent with previous studies (Chen
et al., 2004; Wilbanks et al., 2004), ptc1, a downstream target
gene of Hedgehog signaling, was significantly disrupted in
b-arrestin2, but not b-arrestin1-deficient embryos (Figures
2A–2C, n = 20/38). The cardiac mesodermal marker nkx2.5
was decreased in both b-arrestin1 and b-arrestin2-deficient
embryos, suggesting common roles of b-arrestins in heart devel-
opment (Figures 2D–2F, nE = 33/35, nF = 22/36). Interestingly, the
early hematopoietic and vascular progenitor markers lmo2 and
fli1 were markedly reduced in b-arrestin1 but not b-arrestin2
morphants (Figures 2G–2I, n = 48/51; Figures 2J–2L, n = 36/
40), suggesting specific function of b-arrestin1 during primitive
hematopoiesis. Besides, hematopoietic progenitor markers
runx1 and cmyb were also analyzed, which displayed similar
reduction in b-arrestin1 morphants (Figures S3A–S3C, n = 36/
42; Figures S3D–S3F, n = 43/52). In contrast, the ventral marker
bmp4 (Figures 2M-2O), the pronephric and midbrain-hindbrain
boundary marker pax2.1 (Figures S3G–S3I and S4A–S4C), as
well as the neural markers pax6a and otx2 (Figures S4D–S4F
and S4G-S4I) remained unaffected in both morphants.
To comprehensively understand the distinctive roles of b-ar-
restin1 and b-arrestin2 during zebrafish development, microar-
ray analysis was performed at 12 hpf. Depletion of b-arrestin1
affected a larger set of genes than b-arrestin2, while double
depletions induced even more gene expression changes (Fig-
ure 2P). Notably, few target genes were shared by these two
proteins, and cluster analysis clearly distinguished b-arrestin1
from b-arrestin2 (Figure 2Q). Consistent with the WISH results,
most of the hematopoietic marker genes were found to be
specifically downregulated in b-arrestin1 but not b-arrestin2
Figure 1. b-Arrestin1 Is Evolutionarily Conserved in Zebrafish
(A) The phylogenetic tree of b-arrestins. Phylogenetic tree was built by neighbor-joining algorithm using CLUSTAL X. The scale bar indicates 10% amino
acid substitutions. Vertebrate arrestins were categorized into visual and nonvisual arrestins, while the evolutionary conservation of b-arrestin1 is higher than
b-arrestin2.
(B) Genomic structures of human, mouse and zebrafish b-arrestin1. Black boxes indicate coding exons, and gray boxes indicate noncoding exons.
(C) Antibody staining of b-arrestin1 during zebrafish development. Antibody specifically recognizes zebrafish b-arrestin1 (A1CT) was utilized for whole embryo
immunostaining. The developmental time points were indicated in the panels.
(D) Western blot analyses of b-arrestin1 knockdown efficiency. Embryos without injection (NI, lane 1), injected with 4 ng control morpholino (Ctrl MO, lane 2) or
4 ng b-arrestin1morpholino (Arrb1 MO, lane 3) were harvested at 48 hpf, protein samples were prepared and probed with b-arrestin1-specific antibody (A1CT).
b-Actin was used as the loading control.
(E) Phenotypic analyses of zebrafish embryos at 24 hpf. Embryos without injection (NI), injected with 4 ng control morpholino (Ctrl MO), 4 ng b-arrestin1morpho-
lino (Arrb1 MO), or 4 ng b-arrestin1 morpholino plus 100 pg human b-arrestin1 mRNA (hArrb1 mRNA) were analyzed.
(F) Statistics of zebrafish phenotypic analyses. The number of embryos analyzed in each group was indicated.Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc. 537
Figure 2. b-Arrestin1 Is Required for Zebrafish Embryonic Development
(A–R) Whole-mount in situ hybridization for embryos injected with 4 ng control morpholino (Ctrl MO), 4 ng b-arrestin1morpholino (Arrb1 MO), or 4 ng b-arrestin2
morpholino (Arrb2 MO). Riboprobes to Hedgehog pathway target ptc1 (12 hpf; arrowheads denote aberrant expression in axial mesoderm [A–C]), cardiac marker
nkx2.5 (14 hpf; arrowheads denote decreased expression in cardiac mesoderm [D–F]), hematopoietic markers lmo2 (12 hpf [G–I]) and fli-1 (12 hpf [J–L]) and
ventral marker bmp4 (6 hpf; lateral views with ventral sides on the left [M–O]) were used. All embryos, except for bmp4, are dorsal views with anterior to
the top. (P–R) Zebrafish microarray data analyses. 50 embryos injected with 4 ng control morpholino (Ctrl MO), 4 ng b-arrestin1 morpholino (Arrb1 MO), 4 ng
b-arrestin2 morpholino (Arrb2 MO), or 4 ng b-arrestin1 morpholino plus 4 ng b-arrestin2 morpholino (Double MO) were lysed in Trizol reagent at 12 hpf. RNAs
were extracted and microarray hybridization was performed on an Agilent platform. Venn diagram representation of differentially expressed genes was shown
in (P). Upregulated and downregulated genes (at least 2 folds) were represented separately. Cluster analysis clearly distinguished b-arrestin1 from b-arrestin2
(red, upregulated genes; green, downregulated genes [Q]), with hematopoietic marker genes specifically downregulated in b-arrestin1 but not b-arrestin2 mor-
phants (R). (S) Real-time quantitative PCR verification of hematopoietic marker changes. Data shown are means ± SEM of at least three independent experi-
ments, *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding control.morphants (Figure 2R; Supplemental spreadsheets list all genes
regulated), which could be verified by qPCR analysis (Figure
2S). These findings suggested that b-arrestin1 and b-arrestin2538 Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc.have distinctive functions during zebrafish development, and
that b-arrestin1 may specifically participate in zebrafish hema-
topoiesis.
Figure 3. b-Arrestin1 Critically Regulates Zebrafish Hematopoiesis
(A–F) Whole-mount double in situ hybridization for embryos at 13 hpf. Embryos injected with 4 ng control morpholino (Ctrl MO) or 4 ng b-arrestin1 morpholino
(Arrb1 MO) were hybridized with riboprobes to early hematopoietic precursor marker scl (A and B), erythroid marker gata1 (C and D), and myeloid marker pu.1
(E and F). Embryos were flat-mounted with anterior to the left. Riboprobes to myoD was used to mark the somites for stage matching (red).
(G–N) Whole-mount in situ hybridization for embryos at 24 hpf. Embryos injected as (A-H) were hybridized with riboprobes to scl (G and H), hemoglobin marker
hbbe3 (I and J), lmo2 (K and L), gata1 (M and N). Embryos are lateral views with anterior to the left. Arrows indicated the position of intermediate cell mass (ICM).
(O–R) Embryos derived from transgenic zebrafish lines Tg(lmo2:Rsred) (O and P) and Tg(gata1:EGFP) (Q and R) were injected with b-arrestin1 morpholino and
showed significantly decreased levels of fluorescent intensity. Embryos are lateral views with anterior to the left.
(S–V) Depletion of b-arrestin1 displayed decreased hemoglobin staining by O-dianisidine at 36 hpf and 72 hpf (arrows).To substantiate the function of b-arrestin1 in zebrafish hema-
topoiesis, we examined additional hematopoietic markers using
WISH. At 13 hpf, the early marker of hematopoietic precursors,
scl, was markedly reduced in both the anterior- and posterior-
lateral plate mesoderm (A-LPM and P-LPM) (Figures 3A and
3B, n = 53/57). In addition, the primitive erythroid marker gata1
and the myeloid progenitor marker pu.1 significantly decreased
in b-arrestin1 morphants, implicating that the development of
erythroid and myeloid lineages were both impaired (Figures 3C
and 3D, n = 60/62; Figures 3E and 3F, n = 25/46). Conversely,
injection of b-arrestin1mRNA robustly increased the expression
of hematopoietic progenitor markers, including lmo2 (Figures
S5A and S5B, n = 18/21), cmyb (Figures S5C and S5D, n = 20/
26), fli1 (Figures S5E and S5F, n = 24/25) and scl (Figures S5Gand S5H, n = 18/25), supporting an initiative role of b-arrestin1
during zebrafish hematopoiesis.
It has been shown that hematopoietic cells in the P-LMP
migrate toward the midline to form intermediate cell mass
(ICM) after 20 hpf, where primitive erythropoiesis mainly takes
place. By 24 hpf, the ICM markers scl and lmo2 decreased
dramatically in b-arrestin1 morphants (Figures 3G and 3H, n =
33/35; Figures 3K and 3L, n = 24/29), while the erythroid progen-
itors and mature erythrocyte markers gata1 and hbbe3 nearly
diminished (Figures 3M and 3N, n = 27/27; Figures 3I and 3J,
n = 18/21). In addition, depletion of b-arrestin1 in the hematopoi-
etic Tg(lmo2:Dsred) (Wang et al., 2008a) and Tg(gata1:EGFP) (Fu
et al., 2008) transgenic fish caused significant downregulation of
the fluorescence intensity (Figures 3O and 3P, n = 50/76; FiguresCell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc. 539
3Q and 3R, n = 83/88), further supporting the WISH results.
Finally, O-dianisidine staining of embryos at 36 hpf and 72 hpf
revealed severe reduction of red blood cells in b-arrestin1 mor-
phants (Figures 3S and 3T, n = 35/42; Figures 3U and 3V, n =
46/50).
To determine whether the defects caused by b-arrestin1mor-
pholino are cell autonomous or not, blastula transplantation
experiment was performed.We used Tg(gata1:EGFP) transgenic
embryos as the donor and transplanted about 30 cells to wild-
type embryos at late blastula stage. As indicated by EGFP fluo-
rescence in wild-type embryos at 24 hpf, significant amount
of donor cells differentiated into gata1+ hematopoietic cells in
the ICM regions when injected with control morpholino but not
b-arrestin1 morpholino (Figures S6A–S6D, n = 13; Figures
S6E–S6H, n = 7). Consistently, donor cells injected with con-
trol morpholino differentiated into gata1+ hematopoietic cells
normally when transplanted into b-arrestin1 morphants (Fig-
ures S6I–S6L, n = 10), further demonstrating that the defects
Figure 4. Cdx4-Hox Pathway Is the Down-
stream Target of b-Arrestin1
(A–H) Whole-mount double in situ hybridization for
embryos at 14 hpf. Embryos injected with 4 ng
control morpholino (Ctrl MO) or 4 ng b-arrestin1
morpholino (Arrb1 MO) were hybridized with
riboprobes to cdx4, hoxa9a, hoxb4a and hoxb7a.
Embryos were flat-mounted with anterior to the
left. Riboprobes to myoD was used to mark the
somites for stage matching (red).
(I–R) Whole-mount in situ hybridization monitoring
gata1 and scl expression at 12 hpf. Embryos in-
jected with 4 ng control morpholino (I and N),
4 ng b-arrestin1 morpholino (J and O), 4 ng b-ar-
restin1 morpholino plus 15 pg cdx4 mRNA (K
and P), 4 ng b-arrestin1 morpholino plus 7 pg
hoxa9a mRNA (L and Q), or 4 ng b-arrestin1 mor-
pholino plus 8 pg hoxb4a mRNA (M and R) were
hybridized with riboprobes to gata1 and scl.
Embryos are dorsal views with anterior to the top.
observed are cell autonomous effects
(Figure S6M). Collectively, these results
provide strong evidence supporting that
b-arrestin1 plays a critical role during
zebrafish primitive hematopoiesis.
Cdx4-Hox Pathway Lies
Downstream of b-Arrestin1
The phenotypes and hematopoietic
defects of b-arrestin1 morphants were
reminiscent of embryos depleted of
cdx4 (Figures S7A and S7B, n = 165/
171; Davidson et al., 2003), a caudal-
type homeobox transcription factor that
specifies hematopoietic lineage through
modulating posterior hox gene expres-
sion. Thus, we reasoned that cdx4-hox
pathway may lie downstream of b-ar-
restin1 during zebrafish hematopoiesis.
Consistent with our hypothesis, WISH results revealed that
depletion of b-arrestin1 decreased the expression of cdx4
(Figures 4A and 4B, n = 35/44), but not cdx1a (data not shown).
Besides, hox genes downstream of cdx4, including hoxa9a
(Figures 4C and 4D, n = 46/52), hoxb4a (Figures 4E and 4F, n =
46/48), hoxb7a (Figures 4G and 4H, n = 34/56), hoxb5a (Figures
S7C and S7D, n = 40/58) and hoxb6b (Figures S7E and S7F, n =
41/66), were all significantly reduced in b-arrestin1 morphants.
Subsequent qPCR analysis not only confirmed these WISH
results (Figure S7G), but also showed that most of the hox genes
in zebrafish were downregulated by depletion of b-arrestin1,
suggesting that b-arrestin1 functions as an important regulator
of hox genes (Figure S7H).
When using gata1 and scl as functional read-outs, injection of
cdx4 (Figures 4K and 4P, nK = 40/41, nP = 35/41) mRNAs
restored their expression pattern in b-arresetin1 morphants,
although the tail defects were not completely rescued (data
not shown). Similarly, injection of hoxa9a (Figures 4L and 4Q,540 Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc.
nL = 43/54, nQ = 34/42) or hoxb4a (Figures 4M and 4R, nM = 42/
43, nR = 43/46) mRNA also restored the expression of gata1 and
scl to various extent. Moreover, injection of hoxa9a morpholino
mimicked the phenotypes of b-arrestin1 morphants (Figures
S7I–S7M), while hoxb4a morpholino may induce nonspecific
phenotypes via p53 activation (Figures S7N–S7R). Taken
together, these results suggested that in the absence of b-ar-
restin1, cdx4-hox pathway is disrupted, leading to the observed
hematopoietic defects.
b-Arrestin1 Functionally Interacts with PcG Protein YY1
Previously, Wnt signaling and transcription factor Mespa were
shown to modulate cdx4-hox pathway in zebrafish (Hart et al.,
2007; Lengerke et al., 2008; Shimizu et al., 2005). However,
depletion of b-arrestin1 affected neither the expression of vox
and tbx6, two classical Wnt signaling targets (Figures S8A–
S8D), nor that of mespa (data not shown), suggesting that
Wnt signaling andMespamay be not involved in b-arrestin1-initi-
ated zebrafish hematopoiesis. Since b-arrestin1 regulates signal
transduction and gene transcription mainly through protein inter-
actions (Gao et al., 2004; Wang et al., 2003), we decided to
screen b-arrestin1 interacting partners using yeast two-hybrid
system. We paid special attention to those factors critically
involved in hox gene regulation as well as hematopoiesis, and
finally identified YY1 (Erkeland et al., 2003; Raich et al., 1995).
YY1 is a ubiquitously expressed transcription factor essential
for embryonic development (Donohoe et al., 1999). Besides, it
is also identified as an evolutionarily conserved PcG protein crit-
ically involved in DNA binding, and recruitment of PRC1 and/or
PRC2 complexes to hox gene promoters (Atchison et al., 2003;
Kim et al., 2006). Bio-informatic analysis revealed that several
YY1-specific motifs present in the promoter regions of cdx4
and its downstream hox genes, which suggests that the interac-
tion between b-arrestin1 and YY1 may contribute to the regula-
tion of cdx4-hox pathway.
Coimmunoprecipitation assay confirmed that b-arrestin1
interacts with YY1, but not with another PcG protein Ring1A
(Figure 5A). Interaction between endogenous b-arrestin1 and
YY1 was also seen when using YY1 specific antibody in human
MCF-7 cells (Figure 5B). Moreover, zebrafish b-arrestin1 and
YY1, when coexpressed in HEK293 cells, also interacts with
each other, demonstrating the evolutionary conservation of this
interaction (Figure 5C, lane 1 and lane 2). To ascertain the signif-
icance of this interaction, we screened the bindingmutants using
both bio-informatic calculation and truncation analysis. Consis-
tent with the fact that YY1 is a highly positive charged protein,
the extreme C-terminal region of b-arrestin1, which is enriched
with negative charge amino acids, is critical for its interaction
with YY1 (Figures S9A). Point mutation analyses revealed that
b-arrestin1 D383, 384, 385 A, E404, 405, 406, 407A (designated
as 7M b-arrestin1) had very little, if any, interaction with YY1
(Figure 5C), as was the case for its human ortholog (Figure 5D).
In addition, confocal microscope showed that in HEK293 cell
lines stably expressing single copies of b-arrestin1 (Figure S10A),
wild-type but not 7M b-arrestin1 could colocalize with YY1 in the
cytoplasm (Figures S10B–S10I). Nevertheless, like wild-type
b-arrestin1, 7M b-arrestin1 showed normal interaction with
known b-arrestin1 partners (Figure S9B), and retained classicalfunctions of b-arrestin1, such as ERK activation and receptor
internalization (Figures S9C and data not shown), implicating
that 7M b-arrestin1 is a functionally active mutant.
To explore the significance of b-arrestin1-YY1 interaction
in vivo, we injected GFP-tagged zebrafish YY1 mRNA into one-
cell stage embryos, and observed its sub-cellular localization
during development. YY1 mainly localized in the nucleus before
12 hpf (Figures 5E–5J), but gradually translocated into the
cytoplasm during segmentation periods (Figures 5K–5R). Impor-
tantly, coinjection of b-arrestin1 morpholino inhibited the cyto-
plasmic translocation of YY1, leading to significant nuclear accu-
mulation (Figures 5S–5V). Collectively, these results showed that
b-arrestin1 interacts with YY1 and may negatively regulate its
function through affecting its cytoplasmic translocation.
b-Arrestin1 Relieves PcG Repression and Regulates
Hematopoietic Lineage Specification
To provide direct evidence for the regulation of cdx4-hox path-
way by b-arrestin1-YY1 interaction, whole-embryo chromatin-
immunoprecipitation (E-ChIP) was performed. Depletion of
b-arrestin1 led to increased binding of YY1 to cdx4, hoxa9a
and hoxb4a promoter regions, while coinjection of wild-type,
but not 7M b-arrestin1 mRNA, could reverse this trend (Fig-
ure 6A). To test whether YY1-mediated PcG protein recruitment
is responsible for cdx4-hox pathway repression, promoter occu-
pancy of PRC2 core component Suz12, the corresponding
repressive histone modification H3K27me3, as well as the tran-
scriptional active histone modification H3K4me3 were analyzed
using E-ChIP. Similar to YY1, depletion of b-arrestin1 led to
increased Suz12 binding, elevated level of H3K27me3 and
concomitantly decreased level of H3K4me3 at cdx4, hoxa9a
and hoxb4a promoter regions, which could be rescued by injec-
tion of wild-type, but not 7M b-arrestin1mRNA (Figures 6B–6D).
Promoter occupancy of the PRC1 core component Bmi1 was
also analyzed and revealed no significant changes for these
genes (Figure S11).
Consistent with the E-ChIP results, injection of wild-type
human b-arrestin1 mRNA rescued the posterior defects of
b-arrestin1 deficient embryos (Figure 6E), and restored the
expression of cdx4 (Figure 6G, n = 48/56), gata1 (Figure 6J, n =
52/60) and scl (Figure 6M, n = 41/58), while 7M b-arrestin1
mRNA fail to show any rescue effects (Figures 6E, 6H, 6K, and
6N). Moreover, depletion of either YY1 or Suz12 using morpho-
linos could largely rescue b-arrestin1 morphant phenotypes
(Figures S12A–S12C), and restore normal expression of hemato-
poietic marker genes (Figures S12D–S12I), further supporting
that YY1/Suz12 recruitment repress cdx4-hox pathway activa-
tion.
To detect the upstreamsignal of b-arrestin1 during hematopoi-
esis and cdx4-hox regulation, we used small-molecule inhibitors
to block different signaling pathways, and observed the sub-
cellular localization changes of YY1 in zebrafish embryos. At
24 hpf, inhibition of the Hedgehog pathway (Cyclopamine, Fig-
ures S13E–S13H), Notch pathway (DAPT, Figures S13I–S13L)
or RA pathway (DEAB, Figures S13M–S13P) did not affect the
distribution of YY1, as compared with DMSO treated embryos
(Figures S13A–S13D). In contrast, blockage of the FGF pathway
significantly inhibited the cytoplasmic translocation of YY1,Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc. 541
leading to its nuclear accumulation and a phenotype reminiscent
ofb-arrestin1morphants (SU5402, FiguresS13Q–S13T, anddata
not shown). Consistently, FGF signaling has been shown to regu-
late cdx4-hox pathway in both Xenopus and zebrafish, while the
mechanisms of which remain unclear (Keenan et al., 2006;
Shimizu et al., 2005). Thus, our findings may suggest a potential
role of b-arrestin1 during this process.
Figure 5. b-Arrestin1 Binds to and Seques-
ters PcG Protein YY1
(A) b-Arrestin1 interacts with YY1 but not Ring1A in
HEK293 cells. The indicated expression plasmids
were used to transfect HEK293 cells. IP, immuno-
precipitated; IB, immunoblot. Five percent of total
lysates were loaded as controls.
(B) Endogenous interaction between b-arrestin1
and YY1 in MCF7 cells. Endogenous antibody
was used to immunoprecipitate YY1, b-arrestin1
was probed with b-arrestin1-specific antibody
(A1CT).
(C and D) b-Arrestin1 and YY1 binding mutant
screening using zebrafish (C) and human (D)
proteins (3M, b-arrestin1 D383, 384 and 385A;
4M, b-arrestin1 E404, 405, 406 and 407A; 7M,
b-arrestin1 D383, 384, 385A, E404, 405, 406,
407A). 7M b-arrestin1 showed very little, if not
any, interaction with YY1.
(E–V) Zebrafish confocal microscopy analyses.
200 pg GFP-tagged zebrafish YY1 mRNA was
injected into one-cell stage embryos alone or
together with b-arrestin1 morpholino, and anti-
body staining was performed at 6 hpf (E–G, top
views), 12 hpf (H–J, dorsal views with anterior to
the top), 18 hpf (K–N, lateral views with anterior
to the left) and 24 hpf (O–V, lateral views with ante-
rior to the left) using an anti-GFP antibody.
Hoechst staining was also performed to mark the
nucleus.
Collectively, these data revealed a
model in which b-arrestin1 sequesters
YY1 and relieves the potential repression
of cdx4-hox pathway by PcG proteins,
thus regulating hematopoietic lineage
specification.
DISCUSSION
b-Arrestin1 plays critical roles in signal
transduction and epigenetic regulation
of gene transcription. In this study, we
uncovered that b-arrestin1 is essential
for zebrafish development and critically
involved in primitive hematopoiesis.
Importantly, b-arrestin1 was found to
sequester the PcG recruiter YY1 and
relieve PcG-mediated repression of
cdx4-hox pathway, thus specifying he-
matopoietic lineage commitment. Col-
lectively, our data shed light on a previ-
ously unexpected role of b-arrestin1 in zebrafish
hematopoiesis, as well as a key regulator of PcG proteins and
cdx4-hox pathway.
The developmental role of b-arrestins has long been underes-
timated, since mice with targeted deletion of either b-arrestin1
or b-arrestin2 show no obvious defects. Although studies with
cell culture models suggested potential roles of b-arrestins in542 Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc.
Figure 6. b-Arrestin1 Relieves PcG Repression and Regulates Hematopoietic Lineage Specification
(A–D) Whole-embryo chromatin immunoprecipitation (E-ChIP) assays at 12 hpf. Embryos injected with 4 ng control morpholino (Ctrl MO), 4 ng b-arrestin1 mor-
pholino (Arrb1 MO), 4 ng b-arrestin1 morpholino plus 100 pg human b-arresetin1 mRNA (hArrb1 mRNA) or 4 ng b-arrestin1 morpholino plus 100 pg human 7M
b-arrestin1mRNA (hArrb1 7M mRNA) were probed with antibodies against YY1 (A), Suz12 (B), H3K27me3 (C) and H3K4me3 (D). The presence of cdx4, hoxa9a,
hoxb4a and cdx1a promoter sequences in the input DNA and antibody-bound chromatin segments was analyzed by qPCR. The data obtained were normalized
on the basis of the corresponding input control, andmeans ± SEM from three independent experiments were plotted, *p < 0.05, **p < 0.01, ***p < 0.001 versus the
control morpholino group. Primer sets covering different regions of the same promoter were used and produced similar results.
(E) Phenotypic analyses of embryos at 26 hpf. Embryos injected as (A)–(D) were analyzed.
(F–N) Whole-mount in situ hybridization for embryos at 12 hpf. Embryos injected as in (E) were hybridized with riboprobes to cdx4 (F–H), gata1 (I–K) and scl (L–N).Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc. 543
developmental regulation, in vivo evidences are still lacking. Our
results in zebrafish, together with previous study of zebrafish
b-arrestin2 (Wilbanks et al., 2004), provide strong evidence sup-
porting that both b-arrestin1 and b-arrestin 2 function as impor-
tant regulators during vertebrate development. The different
scenarios in mouse and zebrafish could be explained by the
functional redundancy between the two proteins. In contrast to
their mammalian homologs, zebrafish b-arrestin1 and b-ar-
restin2 appear to have largely nonredundant functions, since
depletion of either protein induces significant and distinctive
developmental defects. b-arrestin1 seems to play a more impor-
tant role during zebrafish development, probably due to its
nuclear localization ability (Figure S2; Kang et al., 2005). Previ-
ously, zebrafish Cox1 and Cox2, two major prostaglandin syn-
thase, were shown to play critical roles in hematopoietic stem
cell (HSC) induction (North et al., 2007), while Cox1 or Cox2
knockout mice are viable and show no apparent defects in
HSC formation (Lorenz et al., 1999). Nevertheless, Cox2
knockout mice demonstrated alterations in hematocrit levels
and impaired recovery from 5-FU-induced bone marrow injury.
Similarly, b-arrestin1 knockout mice also display significant
basal hematology defects (our unpublished data), implicating
a potential role of b-arrestin1 in mammalian hematopoiesis.
Different challenging conditions (e.g., 5-FU or phenylhydrazine
treatment) could be explored to fully understand the function of
b-arrestin1 during mammalian development.
Vertebrate hematopoiesis is a complex and coordinated
process involvingdynamic regulation andmultiple signalingpath-
ways (Orkin and Zon, 2008; Rice et al., 2007). In zebrafish, cdx4-
hoxpathwaywasdemonstrated to be critical for embryonic blood
formation, but the upstream signaling controlling its develop-
mental expression remainunclear. In this study,wedemonstrated
that PcG protein recruitment and the subsequent H3K27me3
modification represents an important repressive mechanism of
cdx4-hox pathway, while the correct expression of b-arrestin1 is
critical for relievingPcG repression andcdx4-hoxpathwayactiva-
tion. Notably, the genes affected by this mechanism may not be
restricted to cdx4-hox pathway, since most of the hox genes
were downregulated by b-arrestin1 depletion (Figure S7H).
Besides, we also analyzed the expression levels and promoter
status of classical PRC2 target genes (extracted by homology
tomammalian targets)wnt1 and hoxa10b (Cao et al., 2008; Kirmi-
zis et al., 2004), and found that thesegeneswere also significantly
downregulated in b-arrestin1morphants (Figure S14A), concom-
itant with increased YY1/Suz12 binding and elevated H3K27me3
levels on their promoter regions. Similarly, coinjection of wild-
type, but not 7M b-arrestin1 mRNA, could reverse this trend
(Figures S14B–S14D). Future genome-wide location analysis
will be helpful to comprehensively explore the genes regulated
by b-arrestin1 and PcG proteins during vertebrate development.
Finally, the discovery that b-arrestin1-mediated YY1 transloca-
tion couldbe affectedby FGFsignaling is rather interesting, espe-
cially becausecdx4-hoxpathwayhasbeensubjected to the regu-
lation by FGF signaling (Keenan et al., 2006; Shimizu et al., 2005).
Thus,b-arrestin1maymediate the responseofcdx4-hoxpathway
to extracellular signals such as FGF.
PcG proteins play fundamental roles in vertebrate develop-
ment and numerous biological processes. Sequence specific544 Cell 139, 535–546, October 30, 2009 ª2009 Elsevier Inc.factors, including GAF and PHO/YY1, have been proposed to
recruit polycomb complexes to target gene promoters, leading
to epigenetic silencing of gene expression (Atchison et al.,
2003; Horard et al., 2000; Mohd-Sarip et al., 2005). However,
the mechanisms by which PcG proteins are excluded from their
target sites remain poorly understood. In this study, we identified
b-arrestin1 as an important negative regulator of PcG proteins
through affecting the translocation of YY1, which provides
a novel mechanism of PcG regulation. Previously, Xenopus
YY1 was found to be retained in the cytoplasm during early
development, the mechanism and functional significance of
which remains elusive (Ficzycz et al., 2001). Our results demon-
strated that interaction with b-arrestin1 may lead to decreased
level of YY1 in the nucleus, concomitant with the absence of
PcG proteins and repressive marks at specific gene promoters,
thus leading to the activation of cdx4-hox pathway. Interestingly,
recent studies in embryonic stem cells (ESCs) revealed that
sequestration of PcG complexes from developmental regulators
contributes to differentiation (Lee et al., 2006; Boyer et al., 2006).
Thus, our studies in zebrafish imply a potential role of b-arrestin1
in PcG protein regulation during ESCs differentiation.
In summary, this study unravels the developmental function
of b-arrestin1 and further illustrates the mechanism by which
b-arrestin1 participates in epigenetic regulation. The finding
that b-arrestin1 functions as an important regulator of PcG
proteins will be of great significance to the study of PcG-medi-
ated epigenetic regulation. The challenge for future studies will
be to better understand the mechanisms of PcG regulation by
b-arrestin1 in ESCs, as well as its relevance to hematopoietic
diseases such as leukemia and anemia.
EXPERIMENTAL PROCEDURES
Zebrafish Maintenance and Embryo Production
Zebrafish maintenance, breeding, and staging were performed as described
previously (Kimmel et al., 1995).
Cloning of Zebrafish b-Arrestin1
Total RNA of 120 hpf zebrafish was extracted with Trizol Reagent (Invitrogen
Life Technology), and reverse-transcribed using BD SMART RACE kit
(TAKARA). For 30 RACE, 30 RACE CDS primer A and GSP1 (50-atgggaga
taaaggcacaagggtgttcaa-30) were used. For 50 RACE, BD SMART II A Oligonu-
cleotide and GSP2 (50-cctcaggcactcagtggacgcctatcaa-30) were used. The
PCR products were cloned into TA vector and sequenced, which has been
submitted to GeneBank (DQ508020).
Morpholino, mRNA Synthesis and Microinjection
Morpholino antisense oligonucleuotides (MO) were obtained fromGene Tools,
LLC. Visual-arrestin MO, b-arrestin2 MO and cdx4 MO have been described
previously (Wilbanks et al., 2004; Davidson et al., 2003). The sequence infor-
mation of other morpholinos is provided in Table S2. To generate mRNAs,
full-length b-arrestin1 (human), cdx4, hoxa9a, and hoxb4a genes were sub-
cloned into pCDNA3 vector (cloning primer sequences are listed in
Table S3), and synthesized using the mMessage mMachine kit (Ambion). For
all the microinjection experiments, a volume of 1 nl was injected into one- to
two-cell stage embryos.
Riboprobe Synthesis and Whole Mount in situ Hybridization
Antisense riboprobes were synthesized using the DIG RNA Labeling kit
(Roche) according to the manufacturer’s instructions. WISH was carried out
as described previously (Gan et al., 2008), and staining was performed with
an alkaline phosphatase substrate kit (SK-5400, Vector Laboratories, Inc.).
Microarray Analysis
Fifty embryos injected with 4 ng control morpholino (Ctrl MO), 4 ng b-arrestin1
morpholino (Arrb1 MO), 4 ng b-arrestin2 morpholino (Arrb2 MO), or 4 ng
b-arrestin1 morpholino plus 4 ng b-arrestin2 morpholino (Double MO) were
lysed in Trizol reagent at 12 hpf. Total RNA were extracted and labeled with
Cy3. Samples were then hybridized onto Zebrafish Oligo Microarray
(G2519F, 4 3 44K, Design ID: 019161) purchased from Agilent Tech. Slides
were washed according to standardized protocol form Agilent Tech, and
scanned using a G2565BA Microarray Scanner System (Agilent). Data were
analyzed using GeneSpring GX software 7.3 (Agilent). The threshold of the
level of changed genes was set at two folds.
Coimmunoprecipitation
For transient transfection, HEK293 cells were cotransfected with HA-tagged
b-arrestin1 and Flag-tagged YY1 expression vectors (GeneCopoeia, Inc.).
48 hr posttransfection, cells were harvested with RIPA buffer (50 mM Tris-HCl
[pH 7.5], 150 mM NaCl, 1% NP-40, 0.1% SDS, 0.5% Sodium deoxycholate
and protease inhibitors), incubated with 20 ul anti-Flag M2 affinity gels
(Sigma) at 4C overnight, and wash three times with RIPA buffer. For endoge-
nous interaction assay, YY1 was immunoprecipitaed with antibody to YY1
(sc-7341; Santa Cruz) in human MCF7 cells, followed by incubation with
20 ml proteinA-agarose beads (Sigma) overnight. Immunoprecipitants and
5% total lysates were denatured in loading buffer supplemented with 1%
BME, separated on 15% SDS-PAGE and transferred to nitrocellulose
membranes. Blots were probed with anti-HA and anti-Flag, or with A1CT
and anti-YY1 antibodies for endogenous interaction assay. The membrane
was detected by secondary fluorescent rabbit antibody CW800.
Real-Time Quantitative PCR
Total RNAs were extracted from 20 zebrafish embryos (12 hpf) using Trizol
reagent (Sigma). RNA was reverse-transcribed using random hexamers and
M-MLV Reverse Transcriptase (Promega). 23 PCR Mix (Tiangen) and Eva
Green (Biotium) were used for the real-time quantitative PCR analysis, with
an MX3000P Stratagene PCR machine. The relative expression values were
normalized against the internal control gapdh (RT-PCR primer sequences
were listed in Table S3).
Embryonic Chromatin Immunoprecipitation (E-ChIP)
E-ChIP was performed as previously described with modifications (Wardle
et al., 2006). Please see details in Supplemental Data.
Fluorescence Microscopy
HEK293 cells were split onto coverslips in 6-well plate and cultured for 48 hr.
Cells were fixed, permeabilized and stained with respective antibodies.
Images were acquired using Leica TCS SP2 confocal fluorescence micros-
copy. For zebrafish antibody staining, embryos were harvested at indicated
time points, fixed and permeabilized, followed by antibody staining using
A1CT or anti-GFP antibody. Secondary antibodies conjugated to Cy3 or
Alexa-488 were used for b-arrestin1 and YY1 staining, respectively. Images
were acquired using Olympus SZX16 system or Olympus confocal micros-
copy.
O-dianisidine Staining
Embryos wee dechorionated with pronase at 36 or 72 hpf, and stained with
1 ml staining buffer (O-dianisidine 0.6 mg/ml; 0.01 M NaAc, [pH 4.5]; 0.65%
hydrogen peroxide; 40% ethanol), flowed by incubation in the dark for
15 min and stop by adding PBST. Images were acquired using Olympus
SZX16 system, and analyzed with Image-pro plus software.
Blastula Transplantation Assay
Tg(gata1:EGFP) transgenic embryos were used as donors and were injected
with 4 ng control MO or Arrb1 MO, as well as the tracer dye Dextran568 at
one-cell stage. Wild-type embryos without treatment, or injected with 4 ng
Arrb1 MO were used as hosts. Embryos were dechorioned by forceps and
deposited at ramps at sphere stage (4 hpf). About 30 donor cells were trans-
planted into host embryos at lateral blastoderm near the margin region, from
which blood and vascular cells derived. Embryos were subsequently grownin 0.33 Danieau’s buffer at 28.5C until 24 hpf. The embryos showing EGFP
expression were picked out under fluorescent stereoscope, and mounted in
1.0% low-melt agarose for imaging with confocal microscopy.
Treatment of Embryos with Small-Molecule Inhibitors
Small-Molecule inhibitors dissolved in DMSO were added into fish facility
water as previously reported: Cyclopamine (100 mM, 5.5 hpf-90% epiboly);
DAPT (100 mM, 4 hpf–24hpf); DEAB (50 mM, 6 hpf–24 hpf) and SU5402
(25 mM, 6 hpf–24 hpf).
Statistical Analysis
Quantitative data are expressed as mean ± SEM. Statistical significance was
determined by one-way analysis of variance followed by the LSD post hoc test
for multiple comparisons. p value of less than 0.05 was considered statistically
significant.
ACCESSION NUMBERS
The GEO accession number for the microarray study is GSE17773.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, fourteen
figures, three tables, and three spreadsheets and can be found with this article
online at http://www.cell.com/supplemental/S0092-8674(09)01112-X.
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